---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-116227"
form_type: "8-K"
ticker: "ABBV"
cik: "0001551152"
company_name: "AbbVie Inc."
filed_at: "2026-10-15T20:00:53+00:00"
generated_at: "2026-10-15T20:02:06.904400+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# AbbVie expands board to 13, appoints Dr. John M. Carethers as Class II director

## Summary
- Board size increased from twelve to thirteen directors on October 14, 2026; Dr. John M. Carethers named a Class II director.
- Carethers is Vice Chancellor for Health Sciences at University of California San Diego and was previously a director of Avantor, Inc.
- Board determined Carethers is independent under NYSE section 303A.02 and AbbVie's Governance and Director Independence Guidelines.
- He was appointed to the Public Policy and Sustainability Committee of the AbbVie board.
- Compensation will follow independent-director terms disclosed in Exhibit 10.5 to AbbVie's Form 10-Q for the quarter ended March 31, 2025.

## SEC filing metadata
- accession: 0001104659-26-116227
- form_type: 8-K
- ticker: ABBV
- cik: 0001551152
- company_name: AbbVie Inc.
- filed_at: 2026-10-15T20:00:53+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551152/000110465926116227/0001104659-26-116227-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551152/000110465926116227/tm2627361d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-116227
- JSON: https://secwatch.observer/filing/0001104659-26-116227.json
- Plain text: https://secwatch.observer/filing/0001104659-26-116227.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.